Cargando…
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869116/ https://www.ncbi.nlm.nih.gov/pubmed/33368829 http://dx.doi.org/10.1002/onco.13657 |